Zeus is delighted to be advising PI Industries Ltd., a $7bn Indian listed company (NSE: PIIND, BSE: 523642), on its £33 million recommended cash offer for Plant Health Care plc (PHC: AIM), drawing upon Zeus’ significant expertise in executing cross border and complex M&A transactions.
The offer represents a premium of 57% to Plant Health Care’s closing price on 25 June 2024, and a 95% premium to its 3-month VWAP. It is expected to close by mid- August 2024, subject to shareholder approval, and is intended to be implemented by means of a scheme of arrangement.
PI Industries Ltd. is a multi-billion dollar leading agrisciences company, manufacturing and distributing a variety of Agri inputs and other fine chemicals for a customer base across Asia, the Americas, Africa and Europe. Headquartered in Mumbai, India, PI was founded in 1946 and exports to over 30 countries, operating out of four global offices. It is listed on the National Stock Exchange of India and the Bombay Stock Exchange.
Plant Health Care is a leading provider of novel patent-protected biological products to global agriculture markets, admitted to trading on AIM. Plant Health Care’s core patented products act as “vaccines for plants” making plants healthier, better able to resist disease and stress, thereby improving crop yield and quality.
Zeus Deal Team
Nick Cowles, James Edis, Louisa Waddell, Emma Burn and John Moran.
Contact
If you would like further information, please get in touch with our team.
This web page constitutes a financial promotion for the purposes of section 21 of the Financial Services and Markets Act 2000 and has been approved by Zeus Capital Limited, which is authorised and regulated by the Financial Conduct Authority.